Back
Coca-Cola FEMSA SAB de CV Vs. Avidity Biosciences, Inc. Industry Stock Comparison
Buy
57
KOF
Coca-Cola FEMSA SAB de CV
Last Price:
$95.05
Seasonality Move:
3.06%
Buy
64
RNA
Avidity Biosciences, Inc.
Last Price:
$72.32
Seasonality Move:
29.53%
Buy
57
Coca-Cola FEMSA SAB de CV (KOF)
is a Buy
Is Coca-Cola FEMSA SAB de CV a Buy, Sell or Hold?
-
The current Coca-Cola FEMSA SAB de CV [KOF] share price is $94.96. The Score for KOF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
KOF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Avidity Biosciences, Inc. (RNA)
is a Buy
Is Avidity Biosciences, Inc. a Buy, Sell or Hold?
-
The current Avidity Biosciences, Inc. [RNA] share price is $72.34. The Score for RNA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
RNA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KOF Stock Price Chart
What is Coca-Cola FEMSA SAB de CV's stock price today?
-
The Coca-Cola FEMSA SAB de CV share price today is $94.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KOF is experiencing slight buying pressure.
RNA Stock Price Chart
What is Avidity Biosciences, Inc.'s stock price today?
-
The Avidity Biosciences, Inc. share price today is $72.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
KOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.61 | Buy |
| Relative Strength Index (14 RSI): | 67.53 | Buy |
| Chaikin Money Flow: | 172912 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (87.49 - 92.51) | Buy |
| Bollinger Bands (100): | (83.03 - 89.31) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 13.57 | Buy |
| Relative Strength Index (14 RSI): | 77.3 | Buy |
| Chaikin Money Flow: | 547948 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.95 - 71.89) | Buy |
| Bollinger Bands (100): | (42.54 - 68.1) | Buy |
KOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.93 | Buy |
| 20-day SMA: | 90.59 | Buy |
| 50-day SMA: | 88.06 | Buy |
| 200-day SMA: | 89.46 | Buy |
| 8-day EMA: | 92.77 | Buy |
| 20-day EMA: | 91.19 | Buy |
| 50-day EMA: | 88.99 | Buy |
| 200-day EMA: | 87.84 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.87 | Buy |
| 20-day SMA: | 71.59 | Buy |
| 50-day SMA: | 66.05 | Buy |
| 200-day SMA: | 42.99 | Buy |
| 8-day EMA: | 38.2 | Buy |
| 20-day EMA: | 18.71 | Buy |
| 50-day EMA: | 8.16 | Buy |
| 200-day EMA: | 2.13 | Buy |
Coca-Cola FEMSA SAB de CV Earnings Growth & KOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.92 per share.
Avidity Biosciences, Inc. Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.63 per share, and a decrease next year of $0.40 per share.
Coca-Cola FEMSA SAB de CV Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||